TY - JOUR
T1 - Characterization of the normal progesterone and placental protein 14 responses to human chorionic gonadotropin stimulation in the luteal phase
AU - Batista, M. C.
AU - Cartledge, T. P.
AU - Nieman, L. K.
AU - Bravo, N.
AU - Loriaux, D. L.
AU - Merriam, G. R.
N1 - Funding Information:
Received July 9, 1993; revised and accepted November 12, 1993. * Supported in part by grant 86/2520-2, Funda<;ao de Amparo a Pesquisa do Estado de Sao Paulo, Sao Paulo, Brazil; and by a grant from Serono Laboratories, Norwell, Massachusetts. t Presented in part at the 45th Annual Meeting of The American Fertility Society, San Francisco, California, November 11 to 16,1989. t Developmental Endocrinology Branch, National Institute of Child Health and Human Development. § Present address: Department of Endocrinology, Hospital das Clinicas, University of Sao Paulo, Sao Paulo, Brazil.
PY - 1994
Y1 - 1994
N2 - Objective: To examine whether midluteal phase administration of the luteotrophic hormone hCG can result in higher and more stable serum levels than random sampling of P and placental protein 14 (PP14). Design: Prospective controlled clinical study. Setting: Normal human volunteers in an academic research environment. Participants: Twenty-six fertile, regularly cycling women. Interventions: Blood samples were drawn at 0, 3, 6, 9, 12, 18, and 24 hours and then daily for the next 6 days, after a single IM injection of 5,000 IU hCG or saline given on day 5, 7, or 9 after the LH surge, as detected by rapid plasma assays. Main Outcome Measures: Serum P and PP14 measurements. Results: Peak P and PP14 concentrations occurred at 6 hours and 5 days, respectively, after hCG stimulation on luteal phase day 9. Progesterone but not PP14 levels were significantly higher and less variable after hCG than after saline administration on this day. Progesterone responses exceeded 11.0 ng/mL (35.0 nmol/L) in all women, suggesting that this represents the cutoff limit for normal luteal function. Because PP14 responses were highly variable and inconsistent, it was not possible to determine a threshold for normal endometrial function. Conclusions: Midluteal phase administration of hCG in normal women induces consistent serum P levels > 11.0 ng/ml (35.0 nmol/L) but highly variable PP14 responses.
AB - Objective: To examine whether midluteal phase administration of the luteotrophic hormone hCG can result in higher and more stable serum levels than random sampling of P and placental protein 14 (PP14). Design: Prospective controlled clinical study. Setting: Normal human volunteers in an academic research environment. Participants: Twenty-six fertile, regularly cycling women. Interventions: Blood samples were drawn at 0, 3, 6, 9, 12, 18, and 24 hours and then daily for the next 6 days, after a single IM injection of 5,000 IU hCG or saline given on day 5, 7, or 9 after the LH surge, as detected by rapid plasma assays. Main Outcome Measures: Serum P and PP14 measurements. Results: Peak P and PP14 concentrations occurred at 6 hours and 5 days, respectively, after hCG stimulation on luteal phase day 9. Progesterone but not PP14 levels were significantly higher and less variable after hCG than after saline administration on this day. Progesterone responses exceeded 11.0 ng/mL (35.0 nmol/L) in all women, suggesting that this represents the cutoff limit for normal luteal function. Because PP14 responses were highly variable and inconsistent, it was not possible to determine a threshold for normal endometrial function. Conclusions: Midluteal phase administration of hCG in normal women induces consistent serum P levels > 11.0 ng/ml (35.0 nmol/L) but highly variable PP14 responses.
KW - Human chorionic gonadotropin
KW - luteal phase
KW - placental protein 14
KW - progesterone
UR - http://www.scopus.com/inward/record.url?scp=0028207187&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028207187&partnerID=8YFLogxK
U2 - 10.1016/s0015-0282(16)56639-4
DO - 10.1016/s0015-0282(16)56639-4
M3 - Article
C2 - 8150104
AN - SCOPUS:0028207187
SN - 0015-0282
VL - 61
SP - 637
EP - 644
JO - Fertility and sterility
JF - Fertility and sterility
IS - 4
ER -